Evidence map›Paper›PMID 24513446›Full record

ArticleMicrobes and infection2014

Helminth co-infection in Helicobacter pylori infected INS-GAS mice attenuates gastric premalignant lesions of epithelial dysplasia and glandular atrophy and preserves colonization resistance of the stomach to lower bowel microbiota.

Mark T Whary, Sureshkumar Muthupalani, Zhongming Ge, Yan Feng, Jennifer Lofgren, Hai Ning Shi, Nancy S Taylor, Pelayo Correa, James Versalovic, Timothy C Wang and 1 more

Abstract read
In one paragraph

Article in Microbes and infection, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Co-Infection Dynamics ofInternational journal of molecular sciences · 2025
    Review
  3. Article
  4. [Gastric Cancer and Gastric Microbiome].The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2023
    Review
  5. Article
  6. Article
  7. Review
  8. The impact ofFrontiers in medicine · 2022
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Changes in the severity of gastric mucosal inflammation associated with Helicobacter pylori in humans coinfected with  intestinal helminths.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2020
    Article
  15. Dual infective burden of Helicobacter pylori and intestinal parasites: Good or bad news for the host?Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2020
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Mark T WharyDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA. Electronic address: mwhary@mit.edu.
Sureshkumar MuthupalaniDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA.
Zhongming GeDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA.
Yan FengDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA.
Jennifer LofgrenDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA.
Hai Ning ShiMucosal Immunology Laboratory, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Nancy S TaylorDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA.
Pelayo CorreaDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
James VersalovicDepartment of Pathology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Timothy C WangDivision of Digestive and Liver Disease, Columbia University Medical Center, New York, NY, USA.
James G FoxDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA.
Massachusetts Institute of Technology · USColumbia University Irving Medical Center · USMassachusetts General Hospital · USTexas Children's Hospital · USVanderbilt University · US

Funding

TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI YAFFE, MICHAEL B · 1985 to 2020
$25.6M
Reaction and Diffusion of NO in Biological SystemsP01CA026731 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ESSIGMANN, JOHN M · 1985 to 2018
$25.4M
Project 3 - Molecular Signatures of Gastric Carcinogenesis in the Host Response to H. pyloriP01CA028842 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILSON, KEITH T. · 1985 to 2019
$15.8M
Role of Inflamation in Mouse Models of Gastric CancerR01CA093405 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, TIMOTHY CRAGIN · 2001 to 2016
$3.8M
IN VIVO PATHOGENESIS OF HELICOBACTER PYLORIR01AI037750 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI FOX, JAMES G · 1996 to 2009
$3.5M
HELIOBACTER INDUCED HEPATITIS AND TUMORIGENESISR01CA067529 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI FOX, JAMES G · 1995 to 2009
$3.2M
Biomedical Research Training for Veterinary ScientistsT32OD010978 · OD · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI FOX, JAMES G · 2012 to 2017
$2.2M
H. hepaticus: the pathogenesis of IBDR01DK052413 · NIDDK · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SCHAUER, DAVID B · 1998 to 2007
$2.1M
Immunomodulatory effects of intestinal helminthes on mucosal immunityR01DK082427 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI SHI, HAI NING · 2010 to 2014
$1.9M
Intestinal Lactobacillus and Mucosal ImmunomodulationR01DK065075 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI VERSALOVIC, JAMES · 2007 to 2010
$1.3M
NCI NIH HHS P01 CA026731NCI NIH HHS P01 CA028842NCI NIH HHS P01CA26731NCI NIH HHS R01 CA067529NCI NIH HHS R01 CA093405NCI NIH HHS R01-CA67529NIAID NIH HHS R01 AI037750NIDDK NIH HHS R01 DK052413NIDDK NIH HHS R01DK052413NIDDK NIH HHS R01 DK065075NIDDK NIH HHS R01DK065075NIDDK NIH HHS R01 DK082427NIDDK NIH HHS R01DK082427NIEHS NIH HHS P30 ES002109NIH HHS T32 OD010978
6 · The paper itself

Abstract

Higher prevalence of helminth infections in Helicobacter pylori infected children was suggested to potentially lower the life-time risk for gastric adenocarcinoma. In rodent models, helminth co-infection does not reduce Helicobacter-induced inflammation but delays progression of pre-malignant gastric lesions. Because gastric cancer in INS-GAS mice is promoted by intestinal microflora, the impact of Heligmosomoides polygyrus co-infection on H. pylori-associated gastric lesions and microflora were evaluated. Male INS-GAS mice co-infected with H. pylori and H. polygyrus for 5 months were assessed for gastrointestinal lesions, inflammation-related mRNA expression, FoxP3(+) cells, epithelial proliferation, and gastric colonization with H. pylori and Altered Schaedler Flora. Despite similar gastric inflammation and high levels of proinflammatory mRNA, helminth co-infection increased FoxP3(+) cells in the corpus and reduced H. pylori-associated gastric atrophy (p < 0.04), dysplasia (p < 0.02) and prevented H. pylori-induced changes in the gastric flora (p < 0.05). This is the first evidence of helminth infection reducing H. pylori-induced gastric lesions while inhibiting changes in gastric flora, consistent with prior observations that gastric colonization with enteric microbiota accelerated gastric lesions in INS-GAS mice. Identifying how helminths reduce gastric premalignant lesions and impact bacterial colonization of the H. pylori infected stomach could lead to new treatment strategies to inhibit progression from chronic gastritis to cancer in humans.

Indexed as

AnimalsAtrophyCoinfectionDisease Models, AnimalDrug Resistance, BacterialGastric MucosaHelicobacter InfectionsHelminthiasisMaleMiceMice, TransgenicMicrobiotaAltered Schaedler FloraGastric cancerHelicobacter pyloriHeligmosomoides polygyrusINS-GAS mice

Identifiers

PMID24513446
PMCPMC4030519
OpenAlexW2054562539

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.